222 related articles for article (PubMed ID: 34234737)
21. Role of miR-101 in pheochromocytoma patients with SDHD mutation.
Zong L; Meng L; Shi R
Int J Clin Exp Pathol; 2015; 8(2):1545-54. PubMed ID: 25973039
[TBL] [Abstract][Full Text] [Related]
22. Inherited mutations in pheochromocytoma and paraganglioma: why all patients should be offered genetic testing.
Fishbein L; Merrill S; Fraker DL; Cohen DL; Nathanson KL
Ann Surg Oncol; 2013 May; 20(5):1444-50. PubMed ID: 23512077
[TBL] [Abstract][Full Text] [Related]
23. Absence of the BRAF V600E mutation in pheochromocytoma.
Paulsson JO; Svahn F; Welander J; Brunaud L; Söderkvist P; Gimm O; Stenman A; Juhlin CC
J Endocrinol Invest; 2016 Jun; 39(6):715-6. PubMed ID: 26710756
[TBL] [Abstract][Full Text] [Related]
24. Somatic mutations in H-RAS in sporadic pheochromocytoma and paraganglioma identified by exome sequencing.
Crona J; Delgado Verdugo A; Maharjan R; Stålberg P; Granberg D; Hellman P; Björklund P
J Clin Endocrinol Metab; 2013 Jul; 98(7):E1266-71. PubMed ID: 23640968
[TBL] [Abstract][Full Text] [Related]
25. First continuous human pheochromocytoma cell line: KNA. Biological, cytogenetic and molecular characterization of KNA cells.
Pfragner R; Behmel A; Smith DP; Ponder BA; Wirnsberger G; Rinner I; Porta S; Henn T; Niederle B
J Neurocytol; 1998 Mar; 27(3):175-86. PubMed ID: 10640177
[TBL] [Abstract][Full Text] [Related]
26. Questioning the pathogenic role of the pTyr791Phe mutation of the RET proto-oncogene: Insight from a case report.
Mavromati M; Amsallem M; Jublanc C; Bruckert E; Leenhardt L; Girerd X
Ann Endocrinol (Paris); 2015 Dec; 76(6):690-4. PubMed ID: 26639185
[TBL] [Abstract][Full Text] [Related]
27. Frequent genetic changes in childhood pheochromocytomas.
De Krijger RR; Petri BJ; Van Nederveen FH; Korpershoek E; De Herder WW; De Muinck Keizer-Schrama SM; Dinjens WN
Ann N Y Acad Sci; 2006 Aug; 1073():166-76. PubMed ID: 17102083
[TBL] [Abstract][Full Text] [Related]
28. Whole-exome sequencing defines the mutational landscape of pheochromocytoma and identifies KMT2D as a recurrently mutated gene.
Juhlin CC; Stenman A; Haglund F; Clark VE; Brown TC; Baranoski J; Bilguvar K; Goh G; Welander J; Svahn F; Rubinstein JC; Caramuta S; Yasuno K; Günel M; Bäckdahl M; Gimm O; Söderkvist P; Prasad ML; Korah R; Lifton RP; Carling T
Genes Chromosomes Cancer; 2015 Sep; 54(9):542-54. PubMed ID: 26032282
[TBL] [Abstract][Full Text] [Related]
29. Germline mutations and genotype-phenotype correlation in Asian Indian patients with pheochromocytoma and paraganglioma.
Pandit R; Khadilkar K; Sarathi V; Kasaliwal R; Goroshi M; Khare S; Nair S; Raghavan V; Dalvi A; Hira P; Fernandes G; Sathe P; Rojekar A; Malhotra G; Bakshi G; Prakash G; Bhansali A; Walia R; Kamalanathan S; Sahoo J; Desai A; Bhagwat N; Mappa P; Rajput R; Chandrashekhar SR; Shivane V; Menon P; Lila A; Bandgar T; Shah N
Eur J Endocrinol; 2016 Oct; 175(4):311-23. PubMed ID: 27539324
[TBL] [Abstract][Full Text] [Related]
30. Mastermind Like Transcriptional Coactivator 3 (MAML3) Drives Neuroendocrine Tumor Progression.
Alzofon N; Koc K; Panwell K; Pozdeyev N; Marshall CB; Albuja-Cruz M; Raeburn CD; Nathanson KL; Cohen DL; Wierman ME; Kiseljak-Vassiliades K; Fishbein L
Mol Cancer Res; 2021 Sep; 19(9):1476-1485. PubMed ID: 33986121
[TBL] [Abstract][Full Text] [Related]
31. Adrenal medullary hyperplasia is a precursor lesion for pheochromocytoma in MEN2 syndrome.
Korpershoek E; Petri BJ; Post E; van Eijck CH; Oldenburg RA; Belt EJ; de Herder WW; de Krijger RR; Dinjens WN
Neoplasia; 2014 Oct; 16(10):868-73. PubMed ID: 25379023
[TBL] [Abstract][Full Text] [Related]
32. Pheochromocytoma in rats with multiple endocrine neoplasia (MENX) shares gene expression patterns with human pheochromocytoma.
Molatore S; Liyanarachchi S; Irmler M; Perren A; Mannelli M; Ercolino T; Beuschlein F; Jarzab B; Wloch J; Ziaja J; Zoubaa S; Neff F; Beckers J; Höfler H; Atkinson MJ; Pellegata NS
Proc Natl Acad Sci U S A; 2010 Oct; 107(43):18493-8. PubMed ID: 20937862
[TBL] [Abstract][Full Text] [Related]
33. Anti-tumor effects and potential therapeutic response biomarkers in α-emitting
Ohshima Y; Kono N; Yokota Y; Watanabe S; Sasaki I; Ishioka NS; Sakashita T; Arakawa K
Theranostics; 2019; 9(6):1538-1549. PubMed ID: 31037122
[TBL] [Abstract][Full Text] [Related]
34. Long intergenic noncoding RNA profiles of pheochromocytoma and paraganglioma: A novel prognostic biomarker.
Ghosal S; Das S; Pang Y; Gonzales MK; Huynh TT; Yang Y; Taieb D; Crona J; Shankavaram UT; Pacak K
Int J Cancer; 2020 Apr; 146(8):2326-2335. PubMed ID: 31469413
[TBL] [Abstract][Full Text] [Related]
35. Pheochromocytoma penetrance varies by RET mutation in MEN 2A.
Machens A; Dralle H
Surgery; 2008 May; 143(5):696; author reply 697. PubMed ID: 18436021
[No Abstract] [Full Text] [Related]
36. Genetics of pheochromocytoma and paraganglioma syndromes: new advances and future treatment options.
Vicha A; Musil Z; Pacak K
Curr Opin Endocrinol Diabetes Obes; 2013 Jun; 20(3):186-91. PubMed ID: 23481210
[TBL] [Abstract][Full Text] [Related]
37. Expression of unfolded protein response markers in the pheochromocytoma with Waardenburg syndrome: a case report.
Morita S; Takeshima K; Ariyasu H; Furukawa Y; Kishimoto S; Tsuji T; Uraki S; Mishima H; Kinoshita A; Takahashi Y; Inaba H; Iwakura H; Furuta H; Nishi M; Doi A; Murata SI; Yoshiura KI; Akamizu T
BMC Endocr Disord; 2020 Jun; 20(1):90. PubMed ID: 32571297
[TBL] [Abstract][Full Text] [Related]
38. Updates on the genetics and the clinical impacts on phaeochromocytoma and paraganglioma in the new era.
Pillai S; Gopalan V; Smith RA; Lam AK
Crit Rev Oncol Hematol; 2016 Apr; 100():190-208. PubMed ID: 26839173
[TBL] [Abstract][Full Text] [Related]
39. Integrative analysis of miRNA and mRNA expression profiles in pheochromocytoma and paraganglioma identifies genotype-specific markers and potentially regulated pathways.
de Cubas AA; Leandro-García LJ; Schiavi F; Mancikova V; Comino-Méndez I; Inglada-Pérez L; Perez-Martinez M; Ibarz N; Ximénez-Embún P; López-Jiménez E; Maliszewska A; Letón R; Gómez Graña A; Bernal C; Alvarez-Escolá C; Rodríguez-Antona C; Opocher G; Muñoz J; Megias D; Cascón A; Robledo M
Endocr Relat Cancer; 2013 Aug; 20(4):477-93. PubMed ID: 23660872
[TBL] [Abstract][Full Text] [Related]
40. Targeting pheochromocytoma/paraganglioma with polyamine inhibitors.
Rai SK; Bril F; Hatch HM; Xu Y; Shelton L; Kalavalapalli S; Click A; Lee D; Beecher C; Kirby A; Kong K; Trevino J; Jha A; Jatav S; Kriti K; Luthra S; Garrett TJ; Guingab-Cagmat J; Plant D; Bose P; Cusi K; Hromas RA; Tischler AS; Powers JF; Gupta P; Bibb J; Beuschlein F; Robledo M; Calsina B; Timmers H; Taieb D; Kroiss M; Richter S; Langton K; Eisenhofer G; Bergeron R; Pacak K; Tevosian SG; Ghayee HK
Metabolism; 2020 Sep; 110():154297. PubMed ID: 32562798
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
